Key Highlights
- Shares reached a record peak of $235.92, representing a 117% annual gain
- First quarter 2026 earnings per share of $3.23 exceeded analyst projections of $2.82; sales of $9.5B surpassed the $8.88B estimate
- BMO Capital upgraded its target to $250 while reaffirming an Outperform stance
- The company’s board approved a $4 billion stock repurchase program
- Wall Street consensus points to Moderate Buy with a mean target of $247.50
Shares of Nucor (NUE) reached an unprecedented high of $235.92 during Tuesday’s trading session, continuing a remarkable upward trajectory that has delivered 117% gains over the past twelve months.
The stock commenced trading at $231.99, a dramatic contrast to its 52-week floor of $106.21, underscoring the magnitude of this bullish movement. The equity’s 50-day moving average currently stands at $197.40, while the 200-day average rests at $178.40.
This impressive surge follows the company’s robust first quarter 2026 financial performance. The steel producer delivered earnings per share of $3.23, surpassing Wall Street’s consensus forecast of $2.82 by a notable $0.41 margin.
Total revenue reached $9.5 billion, exceeding analyst expectations of $8.88 billion and marking a substantial 21.3% increase compared to the prior year period. During the corresponding quarter last year, the company generated only $0.77 in earnings per share.
The corporation currently maintains a return on equity of 10.68% and operates with a net margin of 6.82%. Wall Street analysts have projected full-year earnings per share of $14.58.
Wall Street’s Take
BMO Capital elevated its price objective for Nucor to $250 from $235 following the earnings surprise, maintaining its Outperform designation. Analyst Katja Jancic highlighted optimistic forward guidance from company leadership.
Barclays launched coverage with an Overweight recommendation and established a $270 price target. CICC Research similarly initiated coverage with an Outperform rating.
Morgan Stanley increased its target from $180 to $227, although it retained an Equal Weight rating. Conversely, UBS shifted from Buy to Neutral while simultaneously lifting its target to $224.
The collective analyst sentiment indicates a Moderate Buy recommendation, with an average price objective of $247.50. The ratings breakdown includes two Strong Buy ratings, ten Buy ratings, and four Hold ratings.
Institutional Investment Trends
Institutional capital continues flowing into the stock. Seaview Investment Managers established a fresh position during the fourth quarter, acquiring 49,546 shares valued at approximately $8.08 million. The position now represents 3% of the firm’s total portfolio.
AQR Capital Management expanded its holdings by an impressive 580.9% in the second quarter, currently maintaining 653,845 shares worth $84.7 million. Vaughan Nelson expanded its stake by 169% during Q4, while M&T Bank Corp increased its position by 494.5% in the identical timeframe.
In total, institutional ownership accounts for 76.48% of Nucor’s outstanding shares.
The company’s board sanctioned a $4 billion stock repurchase authorization in February, empowering management to buy back up to 9.7% of shares currently outstanding.
Regarding insider transactions, Executive Vice President David A. Sumoski disposed of 33,068 shares on April 30 at an average price of $225.67, generating approximately $7.46 million. Insider Michael D. Keller sold 4,554 shares on May 4 at $225.86 per share.
Throughout the previous 90 days, company insiders have divested 71,818 shares valued at roughly $16.2 million. Insider ownership represents 0.62% of the corporation.
Nucor maintains a market capitalization of $52.83 billion, trades at a price-to-earnings multiple of 22.97, and operates with a debt-to-equity ratio of 0.30.
Wall Street Zen elevated Nucor from Buy to Strong Buy on May 16.



